Lindera obtusiloba Blume Alleviates Non-Alcoholic Fatty Liver Disease Promoted by Nε-(carboxymethyl)lysine
Nutrients · 2024
DOI: 10.3390/nu16142330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Jin-Ah Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Korea Food Research Institute, 245, Nongsaengmyeong-ro, Iseo-myeon, Wanju-gun 55365, Republic of Korea. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Lysine, Glycation End Products, Advanced, Receptor for Advanced Glycation End Products. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Food Research Institute.
Abstract (Originalsprache)
Non-alcoholic fatty liver disease (NAFLD) is a major issue because it is closely associated with metabolic diseases. Advanced glycation end products (AGEs) are implicated as risk factors for steatosis during NAFLD progression. AGEs influence NAFLD progression through a receptor-independent pathway involving AGE cross-link formation and a receptor-dependent pathway that binds to receptors like receptors for advanced glycation end products (RAGE). The objectives of this study are to examine the effect of Lindera obtusiloba Blume (LO) on NAFLD promoted by Nε-(carboxymethyl)lysine (CML), one of the most common dietary AGEs. The anti-glycation effects of LO were evaluated by inhibiting the AGEs formation and AGEs-collagen cross-links breaking. The efficacy of LO against NAFLD promoted by CML was assessed using both in vitro and in vivo models. NAFLD was induced in mice by feeding a high-fat diet and orally administering CML over a period of 12 weeks, and the effects of LO on lipid metabolism and its regulatory mechanisms were investigated. LO showed the effect of inhibited AGEs formation and breakage, and collagen cross-linking. Fed a high-fat diet with administered CML by gavage, LO administration resulted in a reduction in body weight, fat mass, serum triglycerides, total cholesterol, and low-density lipoprotein cholesterol levels. LO reduced hepatic CML accumulation and RAGE expression in mice fed a high-fat diet and orally administered CML. LO alleviated hepatic steatosis accompanied by lipid accumulation and histological damage by suppressing the expression of sterol regulatory element-binding protein 1c, carbohydrate response element binding protein, fatty acid synthase, stearoyl-CoA desaturase1, tumor necrosis factor-α, and interleukin-1β. LO alleviated the MAPK/NF-κB expression by attenuating CML and RAGE expression. Taken together, our results demonstrate that LO alleviates the progression of NAFLD by lowering the levels of AGEs by downregulating CML/RAGE expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Korea Food Research Institute, 245, Nongsaengmyeong-ro, Iseo-myeon, Wanju-gun 55365, Republic of Korea.
- Division of Food Biotechnology, University of Science and Technology, Daejeon 34113, Republic of Korea.
ORCID-Profile: Min Ji Gu, Yu Ra Lee, Donghwan Kim, Sang Keun Ha
Förderung
- Korea Food Research Institute
Zitieren
APA
Lee, J. A., Gu, M. J., Lee, Y. R., Kim, Y., Choi, I., Kim, D., & Ha, S. K. (2024). Lindera obtusiloba Blume Alleviates Non-Alcoholic Fatty Liver Disease Promoted by Nε-(carboxymethyl)lysine. Nutrients. https://doi.org/10.3390/nu16142330
Vancouver
Lee JA, Gu MJ, Lee YR, Kim Y, Choi I, Kim D, et al. Lindera obtusiloba Blume Alleviates Non-Alcoholic Fatty Liver Disease Promoted by Nε-(carboxymethyl)lysine. Nutrients. 2024. doi:10.3390/nu16142330
BibTeX
@article{Lee2024,
author = {Lee, Jin-Ah and Gu, Min Ji and Lee, Yu Ra and Kim, Yoonsook and Choi, Inwook and Kim, Donghwan and Ha, Sang Keun},
title = {Lindera obtusiloba Blume Alleviates Non-Alcoholic Fatty Liver Disease Promoted by Nε-(carboxymethyl)lysine},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16142330}
}
EUVIMED